The "Quad God" is also pretty good at backflips. U.S. figure skating star Ilia Malinin-- who dubbed himself "Quad God" for his ability to land the quadruple axel -- made his debut at at the 2026 Milan ...

Shin Ji-a finished fourth in the women's short program of the team event in figure skating at the Milan-Cortina Winter Olympics in northern Italy on Friday. Shin scored 68.80 points to find herself ...

Beijing, China - South Africa's Minister of Trade, Industry and Competition, Parks Tau, is leading a high-level delegation to Beijing, China, for the Joint Economic Trade Commission (JETC), where he ...

View post: This ‘Very Smooth’ and ‘Really Sharp’ Folding Knife Is 50% Off at Amazon If you want a relatively affordable electric crossover, these are two of the top choices on sale right now, but how ...

CES 2026 was a decisive comeback moment for the Consumer Technology Association’s flagship show. On Jan. 6-9, CTA delivered its largest turnout since before the pandemic. There were 148,000 attendees ...

Artificial Intelligence (AI) has rapidly transformed many aspects of life in the United States, from healthcare and finance to education and entertainment. As AI technologies become more integrated ...

Forbes contributors publish independent expert analyses and insights. Robin Ryan, a career counselor & author covers job search & careers. This voice experience is generated by AI. Learn more. This ...

Researchers have shown that consumer-grade 3D printers and low-cost materials can be used to produce multi-element optical components that enable super-resolution imaging, with each lens costing less ...

From strengthening safeguards and helping countries build resilient nuclear fuel supply chains to enhancing radiation protection for patients, 2026 will be an eventful year for the IAEA and its global ...

The United States is expected to adopt the vaccine schedule used by Denmark, a much smaller country with universal health care. By Amelia Nierenberg and Maya Tekeli Amelia Nierenberg reported from ...

Dec 23 (Reuters) - The U.S. Centers for Medicare and Medicaid Services on Tuesday unveiled a voluntary program to cover GLP-1 drugs for weight-loss and diabetes under Medicaid and Medicare Part D ...